These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1709627)
1. Localization and characterization of substance P binding sites in rat and rabbit eyes. Denis P; Fardin V; Nordmann JP; Elena PP; Laroche L; Saraux H; Rostene W Invest Ophthalmol Vis Sci; 1991 May; 32(6):1894-902. PubMed ID: 1709627 [TBL] [Abstract][Full Text] [Related]
2. [Autoradiographic localization and characterization of the ocular binding sites of the VIP (vasoactive intestinal peptide) in albino rats and rabbits]. Denis P; Dussaillant M; Elena PP; Nordmann JP; Rostene W; Laroche L Ophtalmologie; 1990; 4(1):30-2. PubMed ID: 2174530 [TBL] [Abstract][Full Text] [Related]
3. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder. Burcher E; Buck SH; Lovenberg W; O'Donohue TL J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545 [TBL] [Abstract][Full Text] [Related]
4. Neurokinin receptors and mucosal ion transport in porcine jejunum. Parsons AM; Seybold VS; Chandan R; Vogt J; Larson AA; Murray CR; Soldani G; Brown DR J Pharmacol Exp Ther; 1992 Jun; 261(3):1213-21. PubMed ID: 1376358 [TBL] [Abstract][Full Text] [Related]
5. Characterization and autoradiographic localization of tachykinin receptors in rat gastric fundus. Mussap CJ; Burcher E J Pharmacol Exp Ther; 1993 Aug; 266(2):1043-53. PubMed ID: 8394903 [TBL] [Abstract][Full Text] [Related]
6. Autoradiographic characterization and localization of vasoactive intestinal peptide binding sites in albino rat and rabbit eyes. Denis P; Dussaillant M; Nordmann JP; Elena PP; Saraux H; Rostene W Exp Eye Res; 1991 Mar; 52(3):357-66. PubMed ID: 2015864 [TBL] [Abstract][Full Text] [Related]
7. 3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle. Bergström L; Beaujouan JC; Torrens Y; Saffroy M; Glowinski J; Lavielle S; Chassaing G; Marquet A; D'Orleans-Juste P; Dion S Mol Pharmacol; 1987 Dec; 32(6):764-71. PubMed ID: 2826990 [TBL] [Abstract][Full Text] [Related]
8. Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor. Lew R; Geraghty DP; Drapeau G; Regoli D; Burcher E Eur J Pharmacol; 1990 Aug; 184(1):97-108. PubMed ID: 1698645 [TBL] [Abstract][Full Text] [Related]
9. Binding of the novel ligand [4,5-3H-Leu10]substance P to high-affinity NK-1 receptors on guinea pig lung membranes: modulation by GTP analogs and sulfhydryl modifying agents. Aharony D; Catanese CA; Woodhouse DP J Pharmacol Exp Ther; 1991 Oct; 259(1):146-55. PubMed ID: 1717678 [TBL] [Abstract][Full Text] [Related]
10. High-affinity substance P binding sites of neurokinin-1 receptor type autoradiographically associated with vascular sinuses and high endothelial venules of human lymphoid tissues. Tang SC; Fend F; Müller L; Braunsteiner H; Wiedermann CJ Lab Invest; 1993 Jul; 69(1):86-93. PubMed ID: 7687312 [TBL] [Abstract][Full Text] [Related]
11. A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. Beaujouan JC; Torrens Y; Viger A; Glowinski J Mol Pharmacol; 1984 Sep; 26(2):248-54. PubMed ID: 6207421 [TBL] [Abstract][Full Text] [Related]
12. High affinity binding sites for [3H]substance P in urinary bladders of cats with interstitial cystitis. Buffington CA; Wolfe SA J Urol; 1998 Aug; 160(2):605-11. PubMed ID: 9679937 [TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of the substance P receptor in sheep intestinal smooth muscle membranes. Keefer JF; Mong S J Pharmacol Exp Ther; 1990 Oct; 255(1):120-7. PubMed ID: 1698967 [TBL] [Abstract][Full Text] [Related]
14. [3H]neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain. Bergström L; Torrens Y; Saffroy M; Beaujouan JC; Lavielle S; Chassaing G; Morgat JL; Glowinski J; Marquet A J Neurochem; 1987 Jan; 48(1):125-33. PubMed ID: 3025361 [TBL] [Abstract][Full Text] [Related]
15. Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture. Beaujouan JC; Torrens Y; Herbet A; Daguet MC; Glowinski J; Prochiantz A Mol Pharmacol; 1982 Jul; 22(1):48-55. PubMed ID: 6181386 [TBL] [Abstract][Full Text] [Related]
16. Effects of neonatal monosodium glutamate treatment on substance P binding sites in the rat retina. Lee CM; Cheung WT Neurosci Lett; 1988 Oct; 92(3):310-4. PubMed ID: 2462198 [TBL] [Abstract][Full Text] [Related]
17. Localization of substance P binding sites in submucous plexus of guinea pig ileum, using whole-mount autoradiography. Burcher E; Bornstein JC Synapse; 1988; 2(3):232-9. PubMed ID: 2463691 [TBL] [Abstract][Full Text] [Related]
18. Identification and pharmacological characterization of somatostatin receptors in rat lung. Schloos J; Raulf F; Hoyer D; Bruns C Br J Pharmacol; 1997 Jul; 121(5):963-71. PubMed ID: 9222554 [TBL] [Abstract][Full Text] [Related]
19. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site. Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347 [TBL] [Abstract][Full Text] [Related]
20. Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain. Beaujouan JC; Torrens Y; Saffroy M; Glowinski J Neuroscience; 1986 Aug; 18(4):857-75. PubMed ID: 2429231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]